FDA Keeps Its User Fees, but Fails to Gain Important Reforms
PharmExec
OCTOBER 6, 2022
The ‘skinny’ user fee reauthorization tables multiple high-profile proposals.
fda-keeps-its-user-fees-but-fails-to-gain-important-reforms 
52 
User Fees Reauthorized for FDA
Drug Topics
NOVEMBER 17, 2022
FDA keeps its user fees but fails to gain important reforms.
FDA User Fees Reauthorized
BioPharm
OCTOBER 5, 2022
FDA keeps its user fees but fails to gain important reforms.
Let's personalize your content